Peter van Hasselt

Associate Professor - medical

Strategic program(s):

Biography

2020-present Member of the board of the WKZ Research Fund

2020-2022 Manager Research of the Division 'Child' at the UMC Utrecht

2019-present Associate Professor (Universitair hoofddocent UHD)

2017-present Head of Department Metabolic diseases

2017-present 'Opleider' at department of Metabolic Diseases

2017-2020 Head of Cluster C (portfolios Science, Finance, Operational Excellence, Capacity management) at WKZ

2017-2022 Member of Leadership team Division 'Child', UMC Utrecht

2016-2020 Member of the scientific committee of the WKZ Research Fund

2015-present Head of Section Metabolic Diseases NVK

2012-2017 'Plaatsvervangend Opleider' Metabolic Diseases (WKZ)

2009-present Staff member at department of Metabolic Diseases

2007-present Pediatrician for Metabolic Diseases, Wilhelmina Children’s Hospital, Utrecht.

2007-2009 Temporary Staff Metabolic Diseases & PhD (WKZ)

2004-2007 Subspecialty training (fellowship) for Metabolic Diseases, Wilhelmina Children’s Hospital. Head: Dr. T.J. de Koning

1998-1999 Physician-researcher (Herseninstituut, Amsterdam)

1997-1998 Pediatrician non-trainee (WKZ, Neonatology)

1995 Student-researcher (UMCG Pharmacology)

Strategic program(s):

Contact

phassel2@umcutrecht.nl

Pure profile

Recent publications

All publications

Key lessons from the first international treatment eligibility committee Daphne H. Schoenmakers, Marije A.B.C. Asbreuk, Tamara Martin, Mareen Datema, Shanice Beerepoot, Michal Inbar-Feigenberg, Samuel Groeschel, Christiane Kehrer, Andreas Øberg, Caroline Sevin, Francesca Fumagalli, Caroline G. Bergner, Päivi Vieira, Annette Bley, Johanna Uusimaa, Morten Andreas Horn, Klára Brožová, Eva Stögmann, Herbert Pichler, Roswitha Lüftinger, Erik A. Eklund, Fanny Mochel, Laura A. Adang, Lucia Laugwitz, Jaap Jan Boelens, Valeria Calbi, Alejandra Darling, Ángeles García-Cazorla, Sabine W. Grønborg, Caroline A. Lindemans, Peter M. van Hasselt, Carla E.M. Hollak, Tom J. de Koning, Dipak Ram, Hanka Dekker, Ludger Schöls, Ayelet Zerem, Holm Graessner, Nicole I. Wolf
European Journal of Paediatric Neurology, 2025, vol. 57, p.72-81

Beyond proline shortage S. G. Sainsbury, T. van den Broek, P. M. van Hasselt
Molecular Genetics and Metabolism, 2025, vol. 145

LIMK1 variants are associated with divergent endocrinological phenotypes and altered exocytosis dynamics Irena J.J. Muffels, Theodore Carter, Holger Rehmann, Sebastiaan J. Vastert, Annemarie A. Verrijn Stuart, Andreas C. Blank, Aurore Garde, Bert van der Zwaag, Iris M. De Lange, Jacques C. Giltay, Koen L.I. van Gassen, Klaas Koop, Cedric S. Asensio, Peter M. van Hasselt
iScience, 2025, vol. 28

Setting the Stage for Treatment of Aminoacyl-tRNA Synthetase (ARS)1-Deficiencies Eva M.M. Hoytema van Konijnenburg, Joline Rohof, Gautam Kok, Peter M. van Hasselt, Clara D. van Karnebeek, Irena J.J. Muffels, Sabine A. Fuchs
Journal of Inherited Metabolic Disease, 2025, vol. 48

Imaging flow cytometry-based cellular screening elucidates pathophysiology in individuals with Variants of Uncertain Significance Irena Josephina Johanna Muffels, Hans R. Waterham, Giuseppina D’Alessandro, Guido Zagnoli-Vieira, Michael Sacher, Dirk J. Lefeber, Celine Van der Vinne, Chaim M. Roifman, Koen L.I. Gassen, Holger Rehmann, Desiree Y. Van Haaften-Visser, Edward S.S. Nieuwenhuis, Stephen P. Jackson, Sabine A. Fuchs, Femke Wijk, Peter van Hasselt
Genome Medicine, 2025, vol. 17

Gene therapy in advanced metachromatic leukodystrophy Daphne H. Schoenmakers, Shanice Beerepoot, Laura A. Adang, Marije A.B.C. Asbreuk, Caroline G. Bergner, Annette E. Bley, Jaap Jan Boelens, Valeria Calbi, Alejandra Darling, Erik Eklund, Ángeles García Cazorla, Sabine W. Grønborg, Samuel Groeschel, Peter M. van Hasselt, Carla E.M. Hollak, Claire Horgan, Simon Jones, Tom de Koning, Lucia Laugwitz, Caroline Lindemans, Pascal Martin, Fanny Mochel, Andreas Øberg, Dipak Ram, Caroline Sevin, Ludger Schöls, Ayelet Zerem, Nicole I. Wolf, Francesca Fumagalli
Protein and Cell, 2025, vol. 16, p.12-15

External positions

bestuurslid - UMD is een samenwerking tussen de zes universitaire metabole centra en de patientenvereniging - UMD

advies - toekomstige medicatie metabole ziekten - ZIN (Zorg Instituut Nederland, previously VWS)